logo

For the Inventor, By the Inventor

Cambridge, MA, United States of America

Surface Oncology, Inc.


USPTO Granted Patents = 13

% Expired Patents = 23.1

Trademarks = 5

Forward Citations = 30

Loading Chart...
Loading Chart...

35 inventors (with patents filed for the assignee):

goldMedal Pamela M Holland (10 out of 13 patents)

silverMedal Bianka Prinz (9 out of 61 patents)

bronzeMedal Andrew Lake (9 out of 12 patents)

4.  Scott C Chappel (9 out of 29 patents)

5.  Jonathan Hill (7 out of 8 patents)

6.  Matthew Rausch (5 out of 6 patents)

7.  Alison Paterson (5 out of 5 patents)

8.  Frank Grosveld (4 out of 12 patents)

9.  Michael Warren (4 out of 4 patents)

10.  Christine Miller (3 out of 4 patents)

11.  Nels P Nielson (3 out of 13 patents)

12.  Nadthakarn Boland (3 out of 8 patents)

13.  Kevin Schutz (3 out of 4 patents)

14.  John Bukowski (3 out of 4 patents)

15.  Jennifer Symonds (3 out of 3 patents)


13 patents:

1. 12358978 - Anti-IL-27 antibodies and uses thereof (2025-07-15),
2. 12162941 - Anti-CD112R compositions and methods (2024-12-10),
3. 11655303 - Anti-CD39 antibody compositions and methods (2023-05-23),
4. 11332524 - Anti-IL-27 antibodies and uses thereof (2022-05-17),
5. 11312783 - Antibody molecules to CD73 and uses thereof (2022-04-26),
6. 11279758 - Anti-CD112R compositions and methods (2022-03-22),
7. 11214619 - Anti-CD112R compositions and methods (2022-01-04),
8. 10793637 - Antibodies that bind CD39 and uses thereof (2020-10-06),
9. 10738128 - Antibodies that bind CD39 and uses thereof (2020-08-11),
10. 10570201 - Anti-CD47 antibodies and methods of use (2020-02-25),
11. 10442858 - Anti-CD47 antibodies and methods of use (2019-10-15),
12. 9803016 - Anti-CD47 antibodies and methods of use (2017-10-31),
13. 9650441 - Anti-CD47 antibodies and methods of use (2017-05-16),
Company Overview
Surface Oncology, Inc. is a biotechnology company based in Cambridge, MA, focused on developing innovative immunotherapies for cancer treatment. The company specializes in harnessing the immune system to target and destroy cancer cells, with a strong emphasis on advancing its proprietary antibody and cell therapy platforms. Surface Oncology aims to address unmet medical needs in oncology by exploring novel approaches to enhance the efficacy of cancer therapies, ultimately improving patient outcomes in the fight against cancer.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

Surface Oncology, Inc. USPTO Patent Assignee Logo
13 Patents

#193 in Cambridge, MA

#1,443 in Massachusetts

#23,854 in US

#45,081 in the World

Cambridge, MA (US)
Cambridge, MA, United States of America

Surface Oncology, Inc.

Forward Citations = 30

35 inventors:

goldMedal Pamela M Holland (10 out of 13 patents)

silverMedal Bianka Prinz (9 out of 61 patents)

bronzeMedal Andrew Lake (9 out of 12 patents)

4.  Scott C Chappel (9 out of 29 patents)

5.  Jonathan Hill (7 out of 8 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Surface Oncology, Inc.. Retrieved from https://idiyas.com/company/surface-oncology

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…